JNJ-54861911 Uses, Dosage, Side Effects and more
JNJ-54861911 is under investigation in clinical trial NCT02211079 (A Study to Assess Effect of JNJ-54861911 on Pharmacokinetics of Cocktail Representatives for Cytochrome P450 (CYP) 3A4, CYP2B6, CYP2C9, and CYP1A2 Substrates).
| Attribute | Details |
|---|---|
| Trade Name | JNJ-54861911 |
| Generic | Atabecestat |
| Atabecestat Other Names | Atabecestat, JNJ-54861911 |
| Type | |
| Formula | C18H14FN5OS |
| Weight | Average: 367.4 Monoisotopic: 367.090309428 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
